Tag: Drug Pricing

Draft pharma policy seeks to bridle NPPA’s pricing powers | domain-b.com

Draft pharma policy seeks to bridle NPPA’s pricing powers | domain-b.com

The draft pharma policy prepared by the government proposes the setting up of an advisory body to assist the National Pharmaceutical Pricing Authority (NPPA) in fixing prices, a move that would take away the drug pricing authority’s powers to fix prices. The draft pharmaceutical policy, prepared by the department of pharmaceuticals under the ministry of […]

Novo And Lilly Head For Diabetes Pricing Battle – Novo Nordisk A/S (NYSE:NVO) | Seeking Alpha

Novo And Lilly Head For Diabetes Pricing Battle – Novo Nordisk A/S (NYSE:NVO) | Seeking Alpha

Novo Nordisk (NYSE:NVO) needs its once-weekly GLP1 agonist semaglutide to be a smash hit, and a head-to-head win against Lilly’s (NYSE:LLY) rival product Trulicity suggests that it could be. FDA approval of semaglutide – which has a PDUFA date of December 5 – looks likely, but Novo will need to think carefully about its pricing […]

House Democrats Start Multiple Sclerosis Drug Price Probe | Bloomberg

House Democrats Start Multiple Sclerosis Drug Price Probe | Bloomberg

House Democrats have started what they called an “in-depth” investigation into the pricing of drugs for neurological condition multiple sclerosis, the latest attempt by U.S. politicians to pressure manufacturers to lower costs. Seven drugmakers — Biogen Inc., Sanofi, Novartis AG, Roche Holding AG, Bayer AG, Merck KGaA’s EMD Serono unit and Teva Pharmaceuticals Industries Ltd. […]

How to Get the Best Deal on EpiPen and Alternatives | Consumer Reports

How to Get the Best Deal on EpiPen and Alternatives | Consumer Reports

Despite a yearlong controversy over how EpiPen auto-injectors are priced, the lifesaving allergy medication is still far from cheap. EpiPen was back in the news Thursday when drugmaker Mylan and the federal government finalized a $465 million settlement over allegations that Mylan overcharged Medicaid for the EpiPen as well as a generic version. The settlement […]

Big pharma pricing out of control: Letters to the editor | DelawareOnline

Big pharma pricing out of control: Letters to the editor | DelawareOnline

Our politicians seem helpless against the abusive pricing activities of pharmaceutical companies.  We’ve seen crazy levels of price increases both in patented drugs and in life saving generic products that have no legitimate reason for 1,000 percent increases just because they are near monopolies for the companies who have seized control of their manufacture and distribution. […]

Natco shifts focus from US to India amidst pricing pressure and competition in former market | Moneycontrol.com

Natco shifts focus from US to India amidst pricing pressure and competition in former market | Moneycontrol.com

Natco’s move comes at a time when Indian drug makers, even mid-sized ones have expanded their R&D budgets and capital expenditure aimed at generics filings in US, the world’s largest and high margin market for generic drugs. It costs around USD 0.5 to 1 million for each ANDA filing. The cost of filing is in […]

China fines domestic medicine companies for monopoly pricing | Post Online Media

China fines domestic medicine companies for monopoly pricing | Post Online Media

The two companies have since restored regular pricing and revived market competition. Monopoly practices in the pharmaceutical sector have been a focus of China’s anti-monopoly supervision for some time. The case will help regulate active pharmaceutical ingredient pricing and ensure a fair environment for medicine purchases and sales, according to the NDRC. The NDRC has […]

Oxera – Leading economic thinking in Oxera’s Agenda articles | Oxera

Oxera – Leading economic thinking in Oxera’s Agenda articles | Oxera

Competition authorities have historically pursued very few cases against excessive pricing. This seems to be changing. In the past 12 months, the rules on abuse of dominance have been invoked to tackle high prices in a range of markets, including pharmaceuticals, musical works, and patents. Together with increased political calls for fairness to consumers, does […]

UK Government’s New Appointment Offers Inside Track on Pricing and Procurement | Pharmaceutical Executive

UK Government’s New Appointment Offers Inside Track on Pricing and Procurement | Pharmaceutical Executive

The UK is entering into unchartered waters between Brexit – offering the opportunity to potentially change approaches to procurement – and negotiating a successor to the main pricing scheme for branded medicines, the Pharmaceutical Price Regulation Scheme (PPRS). To get the inside track, the government has recruited Steve Oldfield as Chief Commercial Officer. Prepping for […]

Sempre Health uses discounts to encourage timely prescription refills | MobiHealthNews

Sempre Health uses discounts to encourage timely prescription refills | MobiHealthNews

Sempre Health, a San Francisco-based company that uses monetary incentives to encourage timely prescription refills, officially launched last week with $2.5 million in funding from Social Capital Partnership, quietly raised last year. Using SMS, Sempre works with pharmacy benefit managers to inform patients about discounts on their prescriptions — and then those discounts change to […]